Dept. of Biomedical Engineering, University of Florida, PO Box 116131, Gainesville, FL 32611, USA.
Biotechnol Prog. 2010 Nov-Dec;26(6):1590-6. doi: 10.1002/btpr.474.
We describe a miniaturized fluid array device for high-throughput cell-free protein synthesis (CFPS), aiming to match the throughput and scale of gene discovery. Current practice of using E. coli cells for production of recombinant proteins is difficult and cost-prohibitive to implement in a high-throughput format. As more and more new genes are being identified, there is a considerable need to have high-throughput methods to produce a large number of proteins for studying structures and functions of the corresponding genes. The device consists of 96 units and each unit is for expression of one protein; thus up to 96 proteins can be produced simultaneously. The function of the fluid array was demonstrated by expression of a variety of proteins, with more than two orders of magnitude reduction in reagent consumption compared with a commercially available CFPS instrument. The protein expression yield in the device was up to 87 times higher for β-glucoronidase than that in a conventional microplate. The concentration of β-galactosidase expressed in the device was determined at 5.5 μg/μL. The feasibility of using the device for drug screening was demonstrated by measuring the inhibitory effects of mock drug compounds on synthesized β-lactamase without the need for harvesting proteins, which enabled us to reduce the analysis time from days to hours.
我们描述了一种用于高通量无细胞蛋白合成 (CFPS) 的微型化流体阵列装置,旨在匹配基因发现的通量和规模。目前使用大肠杆菌细胞生产重组蛋白的做法既困难又难以在高通量格式中实施。随着越来越多的新基因被鉴定出来,人们迫切需要高通量方法来生产大量的蛋白质,以研究相应基因的结构和功能。该装置由 96 个单元组成,每个单元用于表达一种蛋白质;因此,最多可以同时生产 96 种蛋白质。通过表达多种蛋白质证明了流体阵列的功能,与市售的 CFPS 仪器相比,试剂消耗减少了两个数量级以上。与传统微孔板相比,该装置中β-葡糖苷酸酶的蛋白表达产量高达 87 倍。该装置中表达的β-半乳糖苷酶的浓度为 5.5 μg/μL。通过测量模拟药物化合物对合成β-内酰胺酶的抑制作用来证明该装置用于药物筛选的可行性,而无需收获蛋白质,这使我们能够将分析时间从数天缩短到数小时。